Navigation Links
BoydLatexMattresses.com to Focus on Back Pain
Date:7/12/2013

St. Louis, MO (PRWEB) July 12, 2013

According to a recent WebMD article, 8 out of 10 people will suffer from back pain in their life. While many of us will suffer from this pain, few realize the importance of a proper sleep surface in rectifying or solving the cause of the ailment. With this in mind, BoydLatexMattresses.com is focusing on content that will help consumers realize common problems and solutions in dealing with their back pain and mattress purchasing decisions.

The website plans to vastly expand it's content in this area during the remainder of the year as well as other sleep related pain content.

BoydLatexMattresses.com is a pioneer in the specialty sleep segment and constantly strives to develop specialty sleep products that include their line of latex mattresses that provide consumers with a wide array of scientifically created sleep support options. Because everyone has their own sleep patterns, habits and requirements, Boyd Specialty Sleep manufactures a variety of different mattress options including top of the line latex and memory foam beds, waterbeds, airbeds, adjustable beds and a large selection of different accessories. "Better Sleep for a Better Life"

Read the full story at http://www.prweb.com/releases/2013/7/prweb10924290.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1

Related medicine news :

1. BoydLatexMattresses.com releases Sleep Strategy Guide
2. Students focus on creating a better cervical collar
3. Global, common approach to pharmaceutical supply chain integrity the focus of workshop
4. International breast health global summit will focus on supportive care and quality of life
5. Small neural focus groups predict anti-smoking ad success
6. Gastroenterology special issue focuses on new directions of viral hepatitis care and research
7. IU bisexuality studies focus on health, behavior and identity
8. Researchers call for obesity prevention efforts to focus on community-wide systems
9. FirstVitals Health and Wellness, Inc. awarded $4 Million CMS Innovation Grant for Unique Telehealth Diabetes Progam Focused on Glycemic Control and Prevention of Diabetic Foot Complications
10. Traumatic brain injury the focus of American Headache Society scientific conference
11. Tannins in sorghum and benefits focus of university, USDA study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... ... January 23, 2017 , ... The TouchPoint Solution, ... who entered metrics into the product’s app. The data replicates and validates ... that within just 30 seconds of using Buzzies, people experienced a 74 percent ...
(Date:1/24/2017)... Michigan (PRWEB) , ... January 24, 2017 , ... The ... other advocates for drug and alcohol awareness, have worked with communities to designate the ... year, observed January 23-29, 2017, the theme is “Shatter the Myths.” As a ...
(Date:1/23/2017)... ... January 23, 2017 , ... ... localization services for life science companies, has achieved ISO 17100:2015 certification following ... America. ISO 17100 is the globally recognized standard that establishes guidance for ...
(Date:1/23/2017)... ... 23, 2017 , ... The iaedp Foundation, recognized for its ... who treat the full spectrum of eating disorder problems, proudly announces the addition ... of the leading eating disorder treatments centers located throughout the U.S. As partners ...
(Date:1/23/2017)... ... 2017 , ... Sharon Kleyne, America’s leading water researcher, advocate and feared enemy ... of making new water infrastructure a number one priority. “As we usher in a ... infrastructure to become a top priority of our new political change agents.” Kleyne pointed ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... 23, 2017 ArisGlobal, a leading ... announces agClinical 3.3, the latest version of its comprehensive ... science organizations to confidently and efficiently meet new compliance ... the electronic trial master file so that compliance is ... ...
(Date:1/23/2017)... 2017  HOPE BIOSCIENCES announced today that it ... commercialize nuc -gemcitabine™ (APTA-12/HOPE-888) through a licensing ... nuc -Gemcitabine consists of Antisoma,s ... found on many cancer cells, and dFdCMP, an ... conjugates) or SMDCs (small molecule drug conjugates), which ...
(Date:1/23/2017)... 23, 2017  Therabron Therapeutics, Inc., a clinical-stage ... in respiratory care, today announced that the European ... has granted Orphan Drug Designation for Therabron,s CG367 ... Syndrome (BOS).  "We are pleased to ... to treat patients diagnosed with BOS following lung ...
Breaking Medicine Technology: